Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biomarker Utilisation & Commercialisation

10 Sep 2014 - 11 Sep 2014 - London, UK



Bookmark and Share


The ACI Biomarker Utilisation & Commercialisation conference will take place on the 10th & 11th September in London. The event will explore the value of biomarkers from both a clinical and commercial perspective.

The aim of the event is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Attendees will get to meet renowned experts in biomarkers to discuss and debate key issues. All this takes place in a friendly environment designed to encourage networking between participants.

Topics on the agenda:
Benefit from an instructive two-day programme that explores a range of clinical and commercial factors affecting decision-makers in the world of biomarkers, combined with the opportunity for interaction with key opinion leaders.

Presentation Topics Include:
* Creating and Capturing Value with Biomarkers.
* Innovative Commercialisation of Companion Diagnostic Solutions 
* The Use of Human Genetics to Identify Novel Biomarkers for Clinical Trials
* Biomarker Discovery to Diagnostic Development: What are the Challenges? 
* Applying Imaging Biomarkers to Reduce Risk in Drug Development 
* Intellectual Property Protection for Biomarker Utilisation 
* Biomarkers in Personalised Medicine: From Discovery to Repositioning 
* Statistical Innovations in Biomarker Utilisation

Confirmed speaker companies include:
* Teva * Pfizer * Bayer Schering Pharma * Roche Diagnostics * Actelion * Comprehensive Biomarker Center GmbH * TNO * Biogerontology Research Foundation * Eisai * Westminster Genomic Services * Harrison Goddard Foote LLP * Cambridge Consultants * University College Dublin * Lloyd’s Register Quality Assurance (LRQA) * Medimmune * University College Dublin * Imanova *

For a copy of the conference programme or to register your attendance contact Cheryl Williams on +44 (0) 203 141 0623 or email cwilliams@acieu.net


Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!